Peel Therapeutics

United States - Salt Lake City, Utah

• 28/02/2023
• Unknown
• $9,000,000

Over the course of millions of years, nature evolved to create the world’s most awe-inspiring, life-changing health outcomes. Peel Therapeutics translates these evolutionary outliers to develop medicines for patients with cancer and inflammatory diseases.

Using scientific and medical expertise, state-of-the-art technology and drug development knowledge, we redesign what nature offers into medicines for patients by tackling solubility, scalability, and bioavailability.

Our clinical stage therapeutic pipeline treats a spectrum of devastating conditions, with a near-term focus on cancer and inflammation.

At Peel Therapeutics, we push the limits of biology to develop highly effective and safe medicines for patients that transcend the incremental.

Related People

Joshua SchiffmanCo Founder

United States - Salt Lake City, Utah

Dr. Joshua Schiffman is the CEO and Co-Founder of PEEL Therapeutics, delivering evolution-inspired medicine to patients. He also co-founded ItRunsInMyFamily.com, an online family history collection tool. Dr. Schiffman is a Professor of Pediatrics and Investigator at Huntsman Cancer Institute at the University of Utah and the Medical Director for the Family Cancer Assessment Clinic. He also works as a Pediatric Hematologist-Oncologist at Intermountain Primary Children’s Hospital in Salt Lake City, Utah. Dr. Schiffman graduated from the Brown University School of Medicine in 2000, followed by clinical training in Pediatrics and Pediatric Hematology-Oncology at Stanford University from 2000-2008. His academic research and now commercial efforts focus on genomic development of cancer in children and studying animals that naturally are protected from cancer, like elephants. Dr. Schiffman has co-founded several exciting new startup companies to impact cancer diagnosis, treatment, and prevention.

LinkedIn https://www.linkedin.com/in/joshua-schiffman-md-1b202531/